Aridis pharmaceuticals interview to air on bloomberg television u.s. on the redchip money report®

Los gatos, calif., march 26, 2021 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced an interview with vu truong, ph.d.
ARDS Ratings Summary
ARDS Quant Ranking